초록 ▼

An immunotherapy treatment for a patient infected with the virus giving rise to the acquired immune deficiency syndrome (AIDS) and resulting in a breakdown in the patient\s immune response. In this treatment, a supply of plasma is derived from serum-positive individuals who carry the AIDS virus yet

An immunotherapy treatment for a patient infected with the virus giving rise to the acquired immune deficiency syndrome (AIDS) and resulting in a breakdown in the patient\s immune response. In this treatment, a supply of plasma is derived from serum-positive individuals who carry the AIDS virus yet are free of the clinical symptons associated with AIDS or with any AIDS-related complex. The plasma supply is processed to provide a preparation rich in antibodies having neutralizing properties in respect to the AIDS virus, the processed plasma being free of red blood cells and other impurities. The processed plasma is transfused intravenously into the infected patient in a dosage which is safe and efficacious, and the transfusion procedure is repeated at spaced intervals of time until the deficiency in the immune response of the patient is substantially overcome.

대표청구항 ▼

An immunotherapy technique for the treatment of a patient infected with a virus resulting in an immuno-deficiency disease, said technique comprising the steps of: A. deriving a supply of plasma from serum-positive individuals who carry said virus yet are free of clinical symptoms associated therewit

An immunotherapy technique for the treatment of a patient infected with a virus resulting in an immuno-deficiency disease, said technique comprising the steps of: A. deriving a supply of plasma from serum-positive individuals who carry said virus yet are free of clinical symptoms associated therewith; B. processing the plasma so derived to provide a preparation having a high titre of antibodies possessing neutralizing properties in respect to said virus, the processed virus being free of red blood cells and other impurities; C. intravenously transfusing into the infected patient the processed plasma in a dosage which is safe and effective; and D. repeating the transfusion procedure at spaced intervals of time until the deficiency in the patient\s immune system is substantially overcome.